Trump imposes tariff on pharmaceuticals by September 30?

Foretrace AI research

Understand the odds. Examine the reasoning.

Polymarket shows market prices. Foretrace adds AI probability estimates, opposing evidence and a price-dependent outcome or pass decision for each open market.

View a sample AI report No open markets in this event. Closed markets retain historical data.

24h volumeUnavailable

Total volume$59.6K

LiquidityUnavailable

Event end date · UTCSep 30, 2025

Price history

Market probability

Loading price history…

Polymarket · UTC

Sampled market observations, not AI forecasts. Lines connect available observations. Legend values are current provider quotes; chart points may be older.

Outcomes & resolution rules

1 market

These are market-implied probabilities, not AI forecasts. A displayed quote may differ from the price available for your order.

ClosedMarket odds0%

Trump imposes tariff on pharmaceuticals by September 30?

Yes0%Polymarket estimate

No100%Polymarket estimate

Liquidity: Unavailable
Deadline · UTC: Sep 30, 2025
Yes bid / ask: — / 0.1¢
Trading fees: Not flagged by provider

Closed market · historical data

This market is closed. Its historical data remains available.

How research works

Resolution rules

This market will resolve to "Yes" if Donald Trump signs any federal legislation or performs any executive action enacting a tariff on imports of pharmaceuticals into the United States by September 30, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No". Only tariffs specifically targeting pharmaceuticals will qualify. For example, a general tariff (tariffs on all imports into the U.S.) or country-specific tariff (tariffs on all imports from China) will not count toward this market's resolution. Tariffs on pharmaceuticals from a specific country will qualify. Any tariff which is officially enacted within the market's time frame will qualify, regardless of when the tariff goes into effect. This market's primary resolution source will be official information from the Trump administration; however, a consensus of credible information will also be used.